Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women

PHASE2CompletedINTERVENTIONAL

Enrollment

125

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

September 30, 2020

Conditions

Neoadjuvant Operable Breast Cancer

Interventions

DRUG

Fluorouracile

DRUG

Epirubicin

DRUG

Cyclophosphamide

DRUG

Letrozole

DRUG

Palbociclib

Trial Locations (2)

Institut Curie, Paris

Gustave Roussy, Villejuif